GSK-393229/005

Study Sponsor: GSK

Study Title

Phase II Study Of Iodine-131 Anti-B1 Antibody Plus CHOP For Patients With Previously Untreated Mantle Cell Lymphoma

Medicine or Vaccine (generic name)

tositumomab

Sponsor Identification Number

393229/005

Trial Registry Identification Number(#'s)

NCT00992992

Medical Condition

Lymphoma, Mantle-Cell

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

September 2019